Microvascular Angina: Clinical Trials

16 trials for Microvascular Angina, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 5 unknown, 2 not yet recruiting, 2 recruiting. 16 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 416Completed 7, Unknown 5, Not yet recruiting 2, Recruiting 2

Follow Microvascular Angina: new trials by email Literature Review of Microvascular Angina trials Research Report on Microvascular Angina

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Coronary MicrovAscular Diseases Intervention With Compound Danshen Dropping Pills
Compound Danshen Dripping Pills, Placebo - Coronary Microvascular Disease
Phase 4Not yet recruitingQilu Hospital of Shandong University4962026-10-012026-10-21
Clinical Evaluation of Aromatic Wentong in the Treatment of Coronary Microvascular Disease
Kuangxiong Aerosol, Placebo Drug - Coronary Microvascular Disease
Phase 4Not yet recruitingChina-Japan Friendship Hospital5282025-04-012025-04-11
Qishenyiqi Dripping Pill for Coronary Microvascular Disease
Qishenyiqi dripping pills 1 bag, three times a day, Placebo 1 bag, three times a day - Coronary Microvascular Disease
Phase 4RecruitingQilu Hospital of Shandong University1622023-11-082024-11-21
Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease
Bisoprolol, Diltiazem, Placebo - Coronary Microvascular Dysfunction, Microvascular Angina
Phase 4UnknownCharite University, Berlin, Germany1322022-03-042022-03-24
Efficacy and Safety of Shexiang Baoxin Pill in Patients With Ischemia With Non-Obstructive Coronary Artery
Shexiang Baoxin pill(MUSKARDIA), Placebo - Ischemia With Non-Obstructive Coronary Artery, Angina Pectoris
Phase 4CompletedShanghai Hutchison Pharmaceuticals Limited2402021-05-112024-04-23
Evaluate the Efficacy and Safety of MUSK Pill on Coronary Microvascular Dysfunction
MUSK pill - Angina Pectoris, Coronary Heart Disease
Phase 4UnknownShanghai Hutchison Pharmaceuticals Limited2642021-01-282021-08-02
Tongxinluo Capsule for Coronary Microvascular Disease
Tongxinluo, Placebo - Coronary Microvascular Disease
Phase 4UnknownQilu Hospital of Shandong University1002020-01-012020-01-07
Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS)
Compound Danshen Dropping Pills, Placebo - Microvascular Angina
Phase 4RecruitingQilu Hospital of Shandong University1002018-12-182023-10-23
Functional Assessment of the Infart-related Artery With Bioactive and Polymer-free Coronary Stents (The FUNCOMBO Trial)
Stent implantation in the infart-related artery in patients with ST elevation myocardial infarction - Endothelial Dysfunction, Coronary Microvascular Disease
Phase 4CompletedInstitut d'Investigació Biomèdica de Bellvitge602018-11-052020-10-26
Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis
Liraglutide - Microvascular Angina
Phase 4CompletedEva Prescott332015-11-192018-07-11
Effect of ACE-Inhibition on Microvascular Function in Women With Assessed Microvascular Dysfunction
Ramipril (ACE-inhibitor), placebo - Microvascular Angina
Phase 4CompletedBispebjerg Hospital632015-07-012017-02-09
Effect of Ticagrelor on Adenosine-Induced Coronary Flow Reserve in Patients With Microvascular Angina
ticagrelor - Microvascular Angina
Phase 4UnknownSecond Xiangya Hospital of Central South University1402014-11-012014-11-06
Ranolazine and Microvascular Angina by PET in the Emergency Department
Ranolazine, Placebo - Microvascular Angina
Phase 4CompletedYale University312014-04-012017-05-16
Study to Evaluate Effect of Nebivolol on Angina in Women With Microvascular Disease
Nebivolol - Microvascular Angina
Phase 4CompletedMassachusetts General Hospital122013-04-012017-04-20
Understanding of Chest Pain in Microvascular Disease Proved by Cardiac Magnetic Resonance Image
Udenafil, placebo - Microvascular Angina
Phase 4UnknownSamsung Medical Center702011-12-012014-03-26
APEX Study: Effects of Allopurinol on Coronary and Peripheral Endothelial Function in Patients With Cardiac Syndrome X
allopurinol, placebo - Syndrome X
Phase 4CompletedUniversity of Dundee402008-06-012010-06-28

Narrower conditions

Angina Pectoris (3)  ·  Coronary Disease (2)  ·  Angina Pectoris, Variant (1)  ·  Chest Pain (1)  ·  Coronary Artery Disease (1)  ·  Coronary Vasospasm (1)  ·  Emergencies (1)  ·  Heart Diseases (1)  ·  Ischemia (1)  ·  Myocardial Infarction (1)

Broader conditions

Cardiovascular Diseases (16)  ·  Myocardial Ischemia (16)  ·  Vascular Diseases (16)  ·  Heart Diseases (15)  ·  Angina Pectoris (13)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Neurologic Manifestations (5)  ·  Pain (5)  ·  Signs and Symptoms (5)  ·  Chest Pain (4)  ·  Pathologic Processes (3)  ·  Angina, Unstable (1)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Coronary Disease (1)

Interventions

Adrenergic beta-Antagonists (1)  ·  Allopurinol (1)  ·  Angiotensin-Converting Enzyme Inhibitors (1)  ·  Bisoprolol (1)  ·  Cardiotonic Agents (1)  ·  Diltiazem (1)  ·  Liraglutide (1)  ·  Nebivolol (1)  ·  Ramipril (1)  ·  Ranolazine (1)  ·  T89 herbal drug (1)  ·  Ticagrelor (1)  ·  musk (1)  ·  tongxinluo (1)  ·  udenafil (1)

Sponsors

Qilu Hospital of Shandong University (4)  ·  Shanghai Hutchison Pharmaceuticals Limited (2)  ·  Bispebjerg Hospital (1)  ·  Charite University, Berlin, Germany (1)  ·  China-Japan Friendship Hospital (1)  ·  Eva Prescott (1)  ·  Institut d'Investigació Biomèdica de Bellvitge (1)  ·  Massachusetts General Hospital (1)  ·  Samsung Medical Center (1)  ·  Second Xiangya Hospital of Central South University (1)  ·  University of Dundee (1)  ·  Yale University (1)

Countries

China (6)  ·  Denmark (2)  ·  United States (2)  ·  Germany (1)  ·  South Korea (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Basmah Safdar, MD (1)  ·  Chim Lang (1)  ·  Chun Liang (1)  ·  Daoquan Peng, MD, PhD (1)  ·  Eva IB Prescott, MD, DMSc (1)  ·  Eva Prescott, professor (1)  ·  HaiMing Shi, doctor (1)  ·  Josep Gomez Lara, MD PhD (1)  ·  Malissa J Wood, MD (1)  ·  Marie Michelsen, MD (1)  ·  Nandita S Scott, MD (1)  ·  Neus Salvatella, MD (1)  ·  Salvatore Brugaletta, MD PhD (1)  ·  Sung-Ji Park, M.D.,Ph.D. (1)

Results publications

PMID 11320360, PMID 14981009, PMID 15313949, PMID 16720691, PMID 17314342, PMID 18427132, PMID 19151200, PMID 19433695, PMID 20075143, PMID 20220183, PMID 20579539, PMID 21561896, PMID 21586690, PMID 21911339, PMID 22496084, PMID 23868944, PMID 24503784, PMID 24563437, PMID 24705387, PMID 24855202, PMID 25082954, PMID 25154607, PMID 25896352, PMID 28081848, PMID 29883497, PMID 30773266, PMID 33640311, PMID 40020628